Skip to main content
OpenTrials
Recruiting

NCT Number: NCT00398177

Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease

The purpose of this study is to characterize the molecular and cell biology of the tumor cells in lymphoma.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Lymphoma, Non-Hodgkin Hemic and Lymphatic Diseases Hodgkin Disease Hodgkin's Disease Immune System Diseases Immunoproliferative Disorders Lymphatic Diseases Lymphoma Lymphoproliferative Disorders Neoplasms Neoplasms by Histologic Type

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Stanford University School of Medicine

Stanford, California, 94305, United States

Location status: Recruiting

Location contact

Alyssa M Kanegai

CONTACT

[email protected]

650-736-1596

Ronald Levy

PRINCIPAL_INVESTIGATOR

Shoshana Levy

SUB_INVESTIGATOR

About this study

This research involves the study of lymphoma cells in order to better understand how the disease grows and spreads. This study may lead to the development of special materials that could be used, in the future, to treat lymphoma or to follow the response of lymphoma to treatment.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of Hodgkin's disease or non-Hodgkin's lymphoma, any cellular classification, any stage, any grade.
  • Adult or pediatric patients receiving lymph node excision for purposes other than cancer therapy (i.e. tonsillectomy, sleep apnea).
  • A routine procedure for tissue collection is planned.
  • Ability to understand and the willingness to sign a written informed consent.

Exclusion criteria

  • Patients without NHL or Hodgkin's disease

Treatment and study plan

Primary outcomes

  1. Collection of tumor tissue to characterize the molecular and cell biology of tumor cells in lymphoma.

    Time frame: The study will continue indefinitely.

Study contacts

Contact information is provided by the study sponsor or research team.

Alyssa M Kanegai

CONTACT

[email protected]

650-736-1596

Sponsors and collaborators

Lead sponsor

Stanford University

Other

Collaborators

  • Biospect Inc
  • The Leukemia and Lymphoma Society

Registry information

Important dates

Study start
1999
Primary completion
2099
Study completion
2099
First posted
Nov 10, 2006
Registry last updated
Dec 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.